(Q41717750)

7 October 2017

1 reference

title

Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome (English)

1 reference

7 October 2017

main subject

Guillain–Barré syndrome

0 references

1 reference

Campylobacter jejuni

1 reference

Allos BM

1

1 reference

7 October 2017

publication date

1 March 1998

1 reference

Infectious Disease Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

173-184

1 reference

Association between Campylobacter infection and Guillain-Barré syndrome

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Acute conduction block in vitro following exposure to antiganglioside sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter Enteritis: Clinical and Epidemiologic Features

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter enteritis in the United States. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Rheumatic symptoms following an outbreak of campylobacter enteritis: a five year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barre syndrome in Korean children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

HLA antigens in familial Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter enteritis at a university: transmission from eating chicken and from cats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Specific Serotype of Campylobacter jejuni Associated with Ouillain-Barre Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

National surveillance for Guillain-Barré syndrome: January 1978-March 1979

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Anti-GM1 IgA antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serum antibodies to gangliosides in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome and Campylobacter jejuni: a serological study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome: epidemiology of an outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Human infections with Vibrio fetus and a closely related vibrio

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome in mother and newborn child

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Familial Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome associated with campylobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome associated with Campylobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter Diarrhea and Guillain-Barre Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Severe acute Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome after varicella-zoster infection. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Familial Guillain-Barŕe syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Fatalities associated with Campylobacter jejuni infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome associated with Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Antibody detection in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Anti-GM1 antibodies in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

HLA antigens in the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

A prospective study of acute idiopathic neuropathy. II. Antecedent events

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Acute polyneuritis with cranial nerve involvement following Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

HLA-B35 and acute axonal polyneuropathy following Campylobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970416-5

7 January 2021

10.1016/S0891-5520(05)70416-5

Identifiers

DOI

1 reference

7 October 2017

1 reference